Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China flag China · Delayed Price · Currency is CNY
10.55
+0.01 (0.09%)
May 8, 2026, 3:10 PM CST

Aier Eye Hospital Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
22,65122,28120,91020,31316,06914,973
Other Revenue
71.5871.5872.8354.341.1227.91
22,72322,35320,98320,36716,11015,001
Revenue Growth (YoY)
4.17%6.53%3.02%26.43%7.39%25.93%
Cost of Revenue
12,03311,82310,88710,0227,9817,212
Gross Profit
10,69010,53010,09610,3458,1297,788
Selling, General & Admin
5,3785,3615,1434,6383,8513,406
Research & Development
282.28299.81317.98331.32269.9221.18
Other Operating Expenses
62.4649.1863.3745.6544.6241.32
Operating Expenses
5,8215,8355,6415,1224,2433,766
Operating Income
4,8684,6954,4555,2233,8874,022
Interest Expense
-263.41-269.72-255.56-194.82-177.65-164.66
Interest & Investment Income
144.53147.31309.27165.73131.56199.53
Currency Exchange Gain (Loss)
71.371.3-10.3452.41128.9742.88
Other Non Operating Income (Expenses)
-72.19-68.94-40.24-54.19-38.19-44.93
EBT Excluding Unusual Items
4,7484,5754,4585,1923,9314,055
Impairment of Goodwill
-155.97-155.97-187.7-383.61-95.34-216.66
Gain (Loss) on Sale of Investments
89.9798.29334.4-79.42-356.89-448.39
Gain (Loss) on Sale of Assets
13.059.824.270.71-1.250.05
Asset Writedown
-8.2-8.2-6.82-6.11-5.01-4.27
Other Unusual Items
-98.31-93.55-8.24-172.76-137.88-237.77
Pretax Income
4,5894,4254,5944,5513,3353,148
Income Tax Expense
967.52951.92858.15895.02646.06677.85
Earnings From Continuing Operations
3,6213,4733,7363,6562,6892,470
Minority Interest in Earnings
-250.3-232.96-180.07-297.12-164.77-146.56
Net Income
3,3713,2403,5563,3592,5242,323
Net Income to Common
3,3713,2403,5563,3592,5242,323
Net Income Growth
-9.04%-8.88%5.87%33.06%8.65%34.78%
Shares Outstanding (Basic)
9,2759,2689,2449,2189,0479,054
Shares Outstanding (Diluted)
9,2759,2689,2449,2519,0609,054
Shares Change (YoY)
0.27%0.27%-0.07%2.10%0.07%1.48%
EPS (Basic)
0.360.350.380.360.280.26
EPS (Diluted)
0.360.350.380.360.280.26
EPS Growth
-9.29%-9.12%5.95%30.33%8.57%32.82%
Free Cash Flow
3,8913,8803,0524,4123,1022,590
Free Cash Flow Per Share
0.420.420.330.480.340.29
Dividend Per Share
0.1800.1800.1600.1500.0770.071
Dividend Growth
12.48%12.48%6.67%95.09%8.31%3.65%
Gross Margin
47.04%47.11%48.12%50.79%50.46%51.92%
Operating Margin
21.42%21.00%21.23%25.64%24.13%26.81%
Profit Margin
14.84%14.50%16.95%16.49%15.67%15.49%
Free Cash Flow Margin
17.12%17.36%14.54%21.66%19.26%17.27%
EBITDA
5,7715,5865,3015,9114,5074,511
EBITDA Margin
25.39%24.99%25.26%29.02%27.97%30.07%
D&A For EBITDA
902.47891.16845.92687.72619.79489.23
EBIT
4,8684,6954,4555,2233,8874,022
EBIT Margin
21.42%21.00%21.23%25.64%24.13%26.81%
Effective Tax Rate
21.08%21.51%18.68%19.67%19.37%21.53%
Revenue as Reported
22,72322,35320,98320,36716,11015,001
Advertising Expenses
-963.33987.95937.29723.56-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.